Medical Oncology Prof. Dr. Başak Oyan Uluç
✓ Medically verified profileProf. Dr. Başak Oyan Uluç
✓ Medically verified profile
About Prof. Dr. Başak Oyan Uluç
Quick answer
Prof. Dr. Başak Oyan Uluç is a Medical Oncology specialist at Acibadem Altunizade Hospital in İstanbul with over 30 years of experience.
She treats metastatic colorectal cancer, non-small cell lung cancer including ALK-positive and EGFR-mutated disease, extensive-stage small cell lung cancer, pleural mesothelioma, and breast cancers including triple-negative, HER2-positive, and hormone receptor-positive HER2-negative metastatic disease, and provides cancer immunotherapy, chemotherapy, CDK4/6 inhibitor therapy, and HER2-directed neoadjuvant therapy. She consults in Turkish and…
Prof. Başak Oyan Uluç is a medical oncologist and professor with a medical degree from Yeditepe University (2012). She brings extensive clinical experience, most recently serving with Acıbadem Health Group since 2023, where she focuses on evidence-based cancer care and multidisciplinary patient management.
Her professional activities are supported by active memberships in leading national and international organizations, including the European Society for Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), the Turkish Society of Medical Oncology (TTOD), the Turkish Hematology Association (THD), the Turkish Internal Medicine Specialty Society, the Istanbul Medical Chamber of the Turkish Medical Association, the Istanbul Breast Diseases Association, and the Turkish Oncology Group Association (TOG). Known for combining clinical expertise with collaborative research and education, she is committed to advancing oncology practice, improving patient outcomes, and contributing to professional development within the oncology community.
Areas of Expertise
Conditions treated and procedures performed by this specialist.
Education
- 2012Yeditepe University Faculty of Medicine/ Professor
- 2006Yeditepe University Faculty of Medicine / Associate Professor
- 2004Hacettepe University Faculty of Medicine Medical Oncology
- 2004European Certification in Medical Oncology
- 2001Hacettepe University Faculty of Medicine Internal Medicine
- 1996Hacettepe University Faculty of Medicine
Professional Experience
- 2023Acibadem Health Group
- 2021–2024Oncology and Immunotherapy Association/ President
- 2017Dana Farber/Partners Cancer Care Oncology Visiting Physician Program, Boston
- 2017Acibadem University Faculty of Medicine/ Professor
- 2016Acibadem Health Group
- 2014–2016Turkish Society of Medical Oncology (TTOD)/ Secretary General
- 2012–2016Yeditepe University Faculty of Medicine/ Professor
- 2006–2012Yeditepe University Faculty of Medicine /Doctor
- 2004–2006Yeditepe University Faculty of Medicine /Doctor
- 2001–2004Hacettepe University Oncology Institute// Medical Oncology
- 2000–2001Hacettepe University Oncology Institute// Medical Oncology
- 1997–2001Hacettepe University Faculty of Medicine/ Internal Medicine
- 1996Hacettepe University Faculty of Medicine/ Internal Medicine
Professional Memberships
- Europen Society of Medical Oncology (ESMO)
- Turkish Society of Medical Oncology (TTOD)
- American Society of Clinical Oncology (ASCO)
- Turkish Hematology Association (THD)
- Turkish Internal Medicine Specialty Society
- Turkish Medical Association, Istanbul Medical Chamber
- Istanbul Breast Diseases Association
- Turkish Oncology Group Association (TOG)
Selected Publications
- Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer BMC Cancer. 2024 Jan 2;24(1):16.
- A multicenter, retrospective archive study of radiological and clinical features of ALK-positive non-small celi lung cancer patients and crizotinib efficacy Lung Sub-Group Study of the Turkish Oncology Group. Medicine (Baltimore). 2024 May 24;103(21):e3797
- Efficacy of adjuvant capecitabine in residual triple negative breast cancer: a multicenter observational Turkish Oncology Group (TOG) study Expert Opin Pharmacother. 2024 Mar; 25(4):477-484.
- Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2- negative metastatic breast cancer Future Oncol. 2023 May 3.
- Immunotherapy for Lung Cancer J Oncol Sci. 2023;9(2):97-111.
- Established and new treatment roadmaps for pleural mesothelioma: opinions of the Turkish Collaborative Group Current Problems in Cancer, 2023 Dec; 47 (6): 101017
- Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy BMC Cancer (2023) 23:136.
- A Real-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations: a Turkish Oncology Group (TOG) Study J Cancer Res Clin Oncol. 2022 Apr 5.
- Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small celi lung cancer: a real-life data of the Turkish Oncology Group J Cancer Res Clin Oncol. 2022 Jun
- The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locaily advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study Anticancer Drugs. 2022 Aug 1 ;33(7):663-670
Frequently Asked Questions
What is Dr. Başak Oyan Uluç's specialty?
Which hospital does Dr. Başak Oyan Uluç practise at?
What languages can I use when consulting Dr. Başak Oyan Uluç?
How can I book an appointment with Dr. Başak Oyan Uluç?
Is an online video consultation available with Dr. Başak Oyan Uluç?
How many years of experience does Dr. Başak Oyan Uluç have?
Can international patients arrange treatment with Dr. Başak Oyan Uluç?
How do I get a second opinion involving Dr. Başak Oyan Uluç?
A dedicated team, from first message to follow-up
Our international patient office coordinates your appointment, travel and treatment at JCI-accredited Acıbadem hospitals — and stays with you in your own language, every step of the way.
Schedule your appointment with Prof. Dr. Başak Oyan Uluç
Choose a date and time that suits you. Our international patient team will check availability and confirm your appointment — usually within 24 hours.
- 1Choose your date & timePick a preferred day and time slot for your visit.
- 2Share your detailsTell us how to reach you and anything we should know.
- 3We confirm with youOur team confirms the appointment by phone or email.
Request your appointment
This request goes directly to this doctor’s schedule.
Your information stays strictly confidential and is used only to arrange your care.
Hospitals
Medical Units
Treatments Performed
What patients say about Prof. Dr. Başak Oyan Uluç
★★★★★From 2,400+ verified patient reviews“My chronic headache treatment exceeded every expectation I had. Prof. Dr. Uluç listened carefully and built a plan I understood. The nursing staff were attentive and kind throughout.”
“I flew in specifically for immunotherapy and was treated with the utmost professionalism. Prof. Dr. Uluç kept me informed and reassured throughout. The facilities were spotless and modern.”